글루코오스 바이오센서 시장 규모, 점유율 및 동향 분석 보고서 : 유형별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Glucose Biosensors Market Size, Share & Trends Analysis Report By Type (Electrochemical Biosensors, Optical Biosensors), By End Use (Hospitals, Homecare, Diagnostic Centers), By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,272,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,662,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,443,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

글루코오스 바이오센서 시장의 성장과 동향

Grand View Research, Inc.의 최신 보고서에 따르면 글루코오스 바이오센서 세계 시장 규모는 2025년부터 2030년까지 8.5%의 연평균 복합 성장률(CAGR)을 기록하여 2030년에는 156억 8,000만 달러에 달할 것으로 예상됩니다.

글루코오스 바이오센서는 당뇨병 환자의 혈당 모니터링을 돕는 포도당 모니터링 시스템의 필수적인 부분으로, 당뇨병을 관리하고 통제하고 합병증을 예방하는 데 도움이 됩니다. 국제당뇨병연맹은 2021년에 5억 3,700만 명이 당뇨병 진단을 받을 것으로 예상하고 있으며, 2045년에는 7억 8,300만 명에 달할 것으로 예측했습니다.

포도당 모니터링의 새로운 기술 혁신이 시장을 확대하고 있습니다. 땀, 혈액, 타액, 눈물 등 다양한 체액을 이용해 교정할 수 있는 글루코오스 바이오센서 연구가 진행되고 있습니다. 예를 들어, 2021년 10월 펜실베니아 주립대 연구진은 혈액이 아닌 땀에서 포도당을 측정할 수 있는 새로운 기술을 개발하여 바늘을 꽂을 필요가 없는 새로운 기술을 개발했습니다.

시장의 저명한 경쟁사들은 제품 포트폴리오를 확장하고 제조 역량을 강화하기 위해 중견-중소기업에 대한 자금 지원 및 인수 등 다양한 노력을 기울이고 있습니다. 예를 들어, 2020년 8월 Senseonics Holdings는 PHC Holdings Corporation 및 Ascensia Diabetes Care와 전략적 파트너십을 체결했습니다. 이로써 Ascensia는 Senseonics의 CGM 시스템의 세계 독점 판매 파트너가 되었습니다.

글루코오스 바이오센서 시장 보고서 하이라이트

• 유형별로는 전기화학 바이오센서 부문이 민감도, 재현성, 유지보수 용이성으로 인해 2024년 가장 큰 매출 점유율을 차지할 것으로 예상됩니다.
• 글루코오스 바이오센서가 병원 환경에서 널리 사용되고 있고, 당뇨병으로 병원을 찾는 환자 수가 증가함에 따라 병원 최종 용도 부문이 2024년 가장 큰 매출 점유율을 차지할 것으로 예상됩니다.
• 북미는 2024년 가장 큰 매출 점유율을 차지했습니다. 아시아태평양은 의료 시설 및 상환 정책의 개선으로 인해 예측 기간 동안 가장 빠른 CAGR로 확장 될 것으로 예상됩니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 글루코오스 바이오센서 시장 변수, 동향, 범위

• 시장 계통 전망
  • 상위 시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 글루코오스 바이오센서 시장 분석 툴
  • 업계 분석 - Porter의 Five Forces 분석
  • PESTEL 분석

제4장 글루코오스 바이오센서 시장 : 유형 추정·동향 분석

• 부문 대시보드
• 글루코오스 바이오센서 시장 : 유형 변동 분석
• 글루코오스 바이오센서 시장 : 유형별 전망
• 시장 규모와 예측 및 동향 분석(2018-2030년)
• 전기화학 바이오센서
• 광학 바이오센서
• 기타

제5장 글루코오스 바이오센서 시장 : 최종 용도 추정·동향 분석

• 부문 대시보드
• 글루코오스 바이오센서 시장 : 최종 용도 변동 분석
• 최종 용도별 글루코오스 바이오센서 시장 전망
• 시장 규모와 예측 및 동향 분석(2018-2030년)
• 병원
• 홈케어
• 진단센터

제6장 글루코오스 바이오센서 시장 : 지역 추정·동향 분석

• 지역 대시보드
• 지역별 글루코오스 바이오센서 시장변수 분석
• 글루코오스 바이오센서 시장 : 기술과 최종 용도별 지역 추정·동향 분석
• 시장 규모와 예측 및 동향 분석(2018-2030년)
• 북미
  • 미국
  • 캐나다
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 한국
  • 호주
  • 태국
• 라틴아메리카
  • 브라질
  • 멕시코
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제7장 경쟁 구도

• 시장 진출기업 분류
• 주요 기업 개요
  • Abbott.
  • Dexcom Inc.
  • Ascensia Diabetes Care Holdings AG.
  • Nova Diabetes Care
  • F. Hoffmann-La Roche AG
  • Sanofi
  • GlySens Incorporated
  • Trividia Health, Inc.
  • Bayer AG
  • LifeScan IP Holdings,
  • PalmSens
  • Biolinq Incorporated.
  • SB Solutions
  • Nutrix AG

LSH

영문 목차

영문목차

Glucose Biosensors Market Growth & Trends:

The global glucose biosensors market size is expected to reach USD 15.68 billion by 2030, registering a CAGR of 8.5% from 2025 to 2030, according to a new report by Grand View Research, Inc. Glucose biosensors are an essential part of glucose monitoring systems that aid in monitoring blood glucose concentration in diabetic patients, which, in turn, helps them to manage and control diabetes and avoid any further complications. The International Diabetes Federation stated that in 2021, 537 million people were diagnosed with diabetes, and the number is anticipated to reach 783 million by 2045.

Emerging innovations in glucose monitoring are expanding the market. Glucose biosensors that use different body fluids such as sweat, blood, saliva, and tear and can be calibrated, are being increasingly researched. For instance, in October 2021, Penn State University researchers invented a novel technique that can assess glucose in sweat rather than blood, thus removing the need for a needle prick.

The market's prominent competitors are taking different initiatives such as funding and acquisitions of medium and small-sized businesses, in order to expand their product portfolio and enhance their manufacturing capacity. For instance, in August 2020, Senseonics Holdings entered into a strategic partnership with PHC Holdings Corporation and Ascensia Diabetes Care. This allowed Ascensia to be the exclusive global distribution partner for Senseonics' CGM systems.

Glucose Biosensors Market Report Highlights:

• By type, the electrochemical biosensor segment accounted for the largest revenue share in 2024 owing to its sensitivity, reproducibility, and ease of maintenance
• The hospital end-use segment held the largest revenue share in 2024, owing to the extensive use of glucose biosensors in hospital settings and an increase in the number of patients visiting hospitals with diabetes.
• North America accounted for the largest revenue share in 2024. Asia Pacific is anticipated to expand at the fastest CAGR during the forecast period, owing to the improved healthcare facilities and reimbursement policies

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. End Use
  • 1.2.3. Regional scope
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. End Use outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Glucose Biosensors Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing incidence of diabetes
    • 3.2.1.2. Rising demand for minimally and small sized glucose monitoring devices
    • 3.2.1.3. Growing patient awareness
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Presence of alternative method
• 3.3. Glucose Biosensors Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Glucose Biosensors Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Glucose Biosensors Market: Type Movement Analysis
• 4.3. Glucose Biosensors Market by Type Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Electrochemical Biosensor
  • 4.5.1. Electrochemical Biosensor Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Optical Biosensor
  • 4.6.1. Optical Biosensor Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Others
  • 4.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Glucose Biosensors Market: End Use Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Glucose Biosensors Market: End Use Movement Analysis
• 5.3. Glucose Biosensors Market by End Use Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Hospitals
  • 5.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Homecare
  • 5.6.1. Homecare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Diagnostic Centers
  • 5.7.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Glucose Biosensors Market: Regional Estimates & Trend Analysis

• 6.1. Regional Dashboard
• 6.2. Regional Glucose Biosensors Market Movement Analysis
• 6.3. Glucose Biosensors Market: Regional Estimates & Trend Analysis by Technology & End-use
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. North America
  • 6.5.1. North America Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. U.S.
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Competitive Scenario
    • 6.5.2.3. Regulatory Framework
    • 6.5.2.4. Reimbursement scenario
    • 6.5.2.5. U.S. Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Canada
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Competitive Scenario
    • 6.5.3.3. Regulatory Framework
    • 6.5.3.4. Reimbursement scenario
    • 6.5.3.5. Canada Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Europe
  • 6.6.1. Europe Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.2. UK
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Competitive Scenario
    • 6.6.2.3. Regulatory Framework
    • 6.6.2.4. Reimbursement scenario
    • 6.6.2.5. UK Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.3. Germany
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Competitive Scenario
    • 6.6.3.3. Regulatory Framework
    • 6.6.3.4. Reimbursement scenario
    • 6.6.3.5. Germany Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.4. France
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Competitive Scenario
    • 6.6.4.3. Regulatory Framework
    • 6.6.4.4. Reimbursement scenario
    • 6.6.4.5. France Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.5. Italy
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Competitive Scenario
    • 6.6.5.3. Regulatory Framework
    • 6.6.5.4. Reimbursement scenario
    • 6.6.5.5. Italy Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.6. Spain
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Competitive Scenario
    • 6.6.6.3. Regulatory Framework
    • 6.6.6.4. Reimbursement scenario
    • 6.6.6.5. Spain Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.7. Denmark
    • 6.6.7.1. Key Country Dynamics
    • 6.6.7.2. Competitive Scenario
    • 6.6.7.3. Regulatory Framework
    • 6.6.7.4. Reimbursement scenario
    • 6.6.7.5. Denmark Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.8. Sweden
    • 6.6.8.1. Key Country Dynamics
    • 6.6.8.2. Competitive Scenario
    • 6.6.8.3. Regulatory Framework
    • 6.6.8.4. Reimbursement scenario
    • 6.6.8.5. Sweden Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.9. Norway
    • 6.6.9.1. Key Country Dynamics
    • 6.6.9.2. Competitive Scenario
    • 6.6.9.3. Regulatory Framework
    • 6.6.9.4. Reimbursement scenario
    • 6.6.9.5. Norway Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Asia Pacific
  • 6.7.1. Asia Pacific Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.2. Japan
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Competitive Scenario
    • 6.7.2.3. Regulatory Framework
    • 6.7.2.4. Reimbursement scenario
    • 6.7.2.5. Japan Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.3. China
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Competitive Scenario
    • 6.7.3.3. Regulatory Framework
    • 6.7.3.4. Reimbursement scenario
    • 6.7.3.5. China Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.4. India
    • 6.7.4.1. Key Country Dynamics
    • 6.7.4.2. Competitive Scenario
    • 6.7.4.3. Regulatory Framework
    • 6.7.4.4. Reimbursement scenario
    • 6.7.4.5. India Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.5. South Korea
    • 6.7.5.1. Key Country Dynamics
    • 6.7.5.2. Competitive Scenario
    • 6.7.5.3. Regulatory Framework
    • 6.7.5.4. Reimbursement scenario
    • 6.7.5.5. South Korea Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.6. Australia
    • 6.7.6.1. Key Country Dynamics
    • 6.7.6.2. Competitive Scenario
    • 6.7.6.3. Regulatory Framework
    • 6.7.6.4. Reimbursement scenario
    • 6.7.6.5. Australia Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.7. Thailand
    • 6.7.7.1. Key Country Dynamics
    • 6.7.7.2. Competitive Scenario
    • 6.7.7.3. Regulatory Framework
    • 6.7.7.4. Reimbursement scenario
    • 6.7.7.5. Thailand Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.8. Latin America
  • 6.8.1. Latin America Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.2. Brazil
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Competitive Scenario
    • 6.8.2.3. Regulatory Framework
    • 6.8.2.4. Reimbursement scenario
    • 6.8.2.5. Brazil Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.3. Mexico
    • 6.8.3.1. Key Country Dynamics
    • 6.8.3.2. Competitive Scenario
    • 6.7.3.3. Regulatory Framework
    • 6.8.3.4. Reimbursement scenario
    • 6.8.3.5. Mexico Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.4. Argentina
    • 6.8.4.1. Key Country Dynamics
    • 6.8.4.2. Competitive Scenario
    • 6.8.4.3. Regulatory Framework
    • 6.8.4.4. Reimbursement scenario
    • 6.8.4.5. Argentina Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.9. Middle East & Africa
  • 6.9.1. Middle East & Africa Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9.2. South Africa
    • 6.9.2.1. Key Country Dynamics
    • 6.9.2.2. Competitive Scenario
    • 6.9.2.3. Regulatory Framework
    • 6.9.2.4. Reimbursement scenario
    • 6.9.2.5. South Africa Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9.3. Saudi Arabia
    • 6.9.3.1. Key Country Dynamics
    • 6.9.3.2. Competitive Scenario
    • 6.9.3.3. Regulatory Framework
    • 6.9.3.4. Reimbursement scenario
    • 6.9.3.5. Saudi Arabia Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9.4. UAE
    • 6.8.4.1. Key Country Dynamics
    • 6.9.4.2. Competitive Scenario
    • 6.9.4.3. Regulatory Framework
    • 6.9.4.4. Reimbursement scenario
    • 6.9.4.5. UAE Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9.5. Kuwait
    • 6.9.5.1. Key Country Dynamics
    • 6.9.5.2. Competitive Scenario
    • 6.9.5.3. Regulatory Framework
    • 6.9.5.4. Reimbursement scenario
    • 6.9.5.5. Kuwait Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Market Participant Categorization
• 7.2. Key Company Profiles
  • 7.2.1. Abbott.
    • 7.2.1.1. Company overview
    • 7.2.1.2. Financial performance
    • 7.2.1.3. Product benchmarking
    • 7.2.1.4. Strategic initiatives
  • 7.2.2. Dexcom Inc.
    • 7.2.2.1. Company overview
    • 7.2.2.2. Financial performance
    • 7.2.2.3. Product benchmarking
    • 7.2.2.4. Strategic initiatives
  • 7.2.3. Ascensia Diabetes Care Holdings AG.
    • 7.2.3.1. Company overview
    • 7.2.3.2. Financial performance
    • 7.2.3.3. Product benchmarking
    • 7.2.3.4. Strategic initiatives
  • 7.2.4. Nova Diabetes Care
    • 7.2.4.1. Company overview
    • 7.2.4.2. Financial performance
    • 7.2.4.3. Product benchmarking
    • 7.2.4.4. Strategic initiatives
  • 7.2.5. F. Hoffmann-La Roche AG
    • 7.2.5.1. Company overview
    • 7.2.5.2. Financial performance
    • 7.2.5.3. Product benchmarking
    • 7.2.5.4. Strategic initiatives
  • 7.2.6. Sanofi
    • 7.2.6.1. Company overview
    • 7.2.6.2. Financial performance
    • 7.2.6.3. Product benchmarking
    • 7.2.6.4. Strategic initiatives
  • 7.2.7. GlySens Incorporated
    • 7.2.7.1. Company overview
    • 7.2.7.2. Financial performance
    • 7.2.7.3. Product benchmarking
    • 7.2.7.4. Strategic initiatives
  • 7.2.8. Trividia Health, Inc.
    • 7.2.8.1. Company overview
    • 7.2.8.2. Financial performance
    • 7.2.8.3. Product benchmarking
    • 7.2.8.4. Strategic initiatives
  • 7.2.9. Bayer AG
    • 7.2.9.1. Company overview
    • 7.2.9.2. Financial performance
    • 7.2.9.3. Product benchmarking
    • 7.2.9.4. Strategic initiatives
  • 7.2.10. LifeScan IP Holdings,
    • 7.2.10.1. Company overview
    • 7.2.10.2. Financial performance
    • 7.2.10.3. Product benchmarking
    • 7.2.10.4. Strategic initiatives
  • 7.2.11. PalmSens
    • 7.2.11.1. Company overview
    • 7.2.11.2. Financial performance
    • 7.2.11.3. Product benchmarking
    • 7.2.11.4. Strategic initiatives
  • 7.2.12. Biolinq Incorporated.
    • 7.2.12.1. Company overview
    • 7.2.12.2. Financial performance
    • 7.2.12.3. Product benchmarking
    • 7.2.12.4. Strategic initiatives
  • 7.2.13. SB Solutions
    • 7.2.13.1. Company overview
    • 7.2.13.2. Financial performance
    • 7.2.13.3. Product benchmarking
    • 7.2.13.4. Strategic initiatives
  • 7.2.14. Nutrix AG
    • 7.2.14.1. Company overview
    • 7.2.14.2. Financial performance
    • 7.2.14.3. Product benchmarking
    • 7.2.14.4. Strategic initiatives

관련자료